A novel POLH mutation causes XP-V disease and XP-V tumor proneness may involve imbalance of numerous DNA polymerases

Oncology Letters

Volumn 6, Issue 6, 2013, Pages 1583-1590

  Guo, Jia ^a   Zhou, Guilan ^b   Zhang, Wenfeng ^a   Song, Yaling ^a   Bian, Zhuan ^a  

^a Wuhan University   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Mutation; POLH; Xeroderma pigmentosum; XP V

Indexed keywords

COMPLEMENTARY DNA; DNA POLYMERASE;

AGED; ARTICLE; CASE REPORT; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA SEQUENCE; GEL ELECTROPHORESIS; GENE; GENE MUTATION; GENE SILENCING; HELA CELL; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; POLH GENE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; ULTRAVIOLET IRRADIATION; WESTERN BLOTTING; XERODERMA PIGMENTOSUM; XERODERMA PIGMENTOSUM VARIANT;

EID: 84886772784     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1604     Document Type: Article

References (29)

1. Kraemer KH, Lee MM and Scotto J: Xeroderma pigmentosum. Cutaneous, ocular and neurologic abnormalities in 830 published cases. Arch Dermatol 123: 241-250, 1987.
2. Lehmann AR, McGibbon D and Stefanini M: Xeroderma pigmentosum. Orphanet J Rare Dis 6: 70, 2011.
3. Kraemer KH and DiGiovanna JJ: Xeroderma Pigmentosum. In: GeneReviews. Pagon RA, Bird TD, Dolan CR and Stephens K (eds). Seattle, WA, pp1993-2013, 2003.
4. Masutani C, Kusumoto R, Yamada A, et al: The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature 399: 700-704, 1999.
5. Johnson RE, Kondratick CM, Prakash S and Prakash L: hRAD30 mutations in the variant form of xeroderma pigmentosum. Science 285: 263-265, 1999.
6. Inui H, Oh KS, Nadem C, et al: Xeroderma pigmentosum-variant patients from America, Europe and Asia. J Invest Dermatol 128: 2055-2068, 2008.
7. Gratchev A, Strein P, Utikal J and Sergij G: Molecular genetics of Xeroderma pigmentosum variant. Exp Dermatol 12: 529-536, 2003.
8. Broughton BC, Cordonnier A, Kleijer WJ, et al: Molecular analysis of mutations in DNA polymerase eta in xeroderma pigmentosum-variant patients. Proc Natl Acad Sci USA 99: 815-820, 2002.
9. Faili A, Stary A, Delbos F, et al: A backup role of DNA polymerase kappa in Ig gene hypermutation only takes place in the complete absence of DNA polymerase eta. J Immunol 182: 6353-6359, 2009.
10. Kannouche P, Broughton BC, Volker M, Hanaoka F, Mullenders LH and Lehmann AR: Domain structure, localization and function of DNA polymerase eta, defective in xeroderma pigmentosum variant cells. Genes Dev 15: 158-172, 2001.
11. Yuasa M, Masutani C, Eki T and Hanaoka F: Genomic structure, chromosomal localization and identification of mutations in the xeroderma pigmentosum variant (XPV) gene. Oncogene 19: 4721-4728, 2000.
12. Tanioka M, Masaki T, Ono R, et al: Molecular analysis of DNA polymerase eta gene in Japanese patients diagnosed as xeroderma pigmentosum variant type. J Invest Dermatol 127: 1745-1751, 2007.
13. Hentosh P, Benjamin T, Hall L, et al: Xeroderma pigmentosum variant: complementary molecular approaches to detect a 13 base pair deletion in the DNA polymerase eta gene. Exp Mol Pathol 91: 528-533, 2011.
14. Johnson RE, Prakash S and Prakash L: Efficient bypass of a thymine-thymine dimer by yeast DNA polymerase, Poleta. Science 283: 1001-1004, 1999.
15. Ohmori H, Friedberg EC, Fuchs RP, et al: The Y-family of DNA polymerases. Mol Cell 8: 7-8, 2001.
16. Daya-Grosjean L and Sarasin A: The role of UV induced lesions in skin carcinogenesis: an overview of oncogene and tumor suppressor gene modifications in xeroderma pigmentosum skin tumors. Mutat Res 571: 43-56, 2005.
17. Silverstein TD, Johnson RE, Jain R, et al: Structural basis for the suppression of skin cancers by DNA polymerase eta. Nature 465: 1039-1043, 2010.
18. Ziv O, Geacintov N, Nakajima S, Yasui A and Livneh Z: DNA polymerase zeta cooperates with polymerases kappa and iota in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients. Proc Natl Acad Sci USA 106: 11552-11557, 2009.
19. Masuda K, Ouchida R, Hikida M, et al: DNA polymerases eta and theta function in the same genetic pathway to generate mutations at A/T during somatic hypermutation of Ig genes. J Biol Chem 282: 17387-17394, 2007.
20. Song Y, Wang C, Peng B, et al: Phenotypes and genotypes in 2 DGI families with different DSPP mutations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102: 360-374, 2006.
21. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 25: 402-408, 2001.
22. Johnson RE, Washington MT, Prakash S and Prakash L: Fidelity of human DNA polymerase eta. J Biol Chem 275: 7447-7450, 2000.
23. Cruet-Hennequart S, Gallagher K, Sokol AM, Villalan S, Prendergast AM and Carty MP: DNA polymerase eta, a key protein in translesion synthesis in human cells. Subcell Biochem 50: 189-209, 2010.
24. Svoboda DL, Briley LP and Vos JM: Defective bypass replication of a leading strand cyclobutane thymine dimer in xeroderma pigmentosum variant cell extracts. Cancer Res 58: 2445-2448, 1998.
25. Masutani C, Araki M, Yamada A, et al: Xeroderma pigmentosum variant (XP-V) correcting protein from HeLa cells has a thymine dimer bypass DNA polymerase activity. EMBO J 18: 3491-3501, 1999.
26. Bradford PT, Goldstein AM, Tamura D, et al: Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair. J Med Genet 48: 168-176, 2011.
27. Gueranger Q, Stary A, Aoufouchi S, et al: Role of DNA polymerases eta, iota and zeta in UV resistance and UV-induced mutagenesis in a human cell line. DNA Repair (Amst) 7: 1551-1562, 2008.
28. Wang Y, Woodgate R, McManus TP, et al: Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res 67: 3018-3026, 2007.
29. Lemée F, Bergoglio V, Fernandez-Vidal A, et al: DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication and promotes genetic instability. Proc Natl Acad Sci USA 107: 13390-13395, 2010.